Literature DB >> 15379632

Nerve growth factor receptors and signaling in breast cancer.

Laurent Dollé1, Eric Adriaenssens, Ikram El Yazidi-Belkoura, Xuefen Le Bourhis, Victor Nurcombe, Hubert Hondermarck.   

Abstract

Nerve growth factor (NGF) has long been known for its effects on neuronal cell survival and differentiation. This prototypical neurotrophic factor stimulates neurons through two distinct classes of membrane receptors: the TrkA tyrosine kinase receptor, and the tumor necrosis factor receptor family member p75NTR, also known as the common neurotrophin receptor. Somewhat surprisingly, there is a growing body of evidence indicating that NGF is also a major stimulator of breast cancer cell growth. Both the survival and proliferation of breast cancer cells are strongly stimulated by NGF, mediated by TrkA and p75NTR respectively, utilising signaling pathways similar to those described for neurons. In addition, although NGF is produced by breast cancer cells, it is not in normal breast epithelial cells, giving rise to an autocrine stimulation of tumor growth. Therefore, NGF receptors and signaling are thus looking increasingly promising as potential drug targets for breast cancer. Copyright 2004 Bentham Science Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379632     DOI: 10.2174/1568009043332853

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  39 in total

1.  TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.

Authors:  Jamie L Croucher; Radhika Iyer; Nanxin Li; Valentina Molteni; Jon Loren; W Perry Gordon; Tove Tuntland; Bo Liu; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2014-11-14       Impact factor: 3.333

Review 2.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

3.  The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.

Authors:  D J Brennan; D P O'Connor; H Laursen; S F McGee; S McCarthy; R Zagozdzon; E Rexhepaj; A C Culhane; F M Martin; M J Duffy; G Landberg; L Ryden; S M Hewitt; M J Kuhar; R Bernards; R C Millikan; J P Crown; K Jirström; W M Gallagher
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

4.  AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.

Authors:  Radhika Iyer; Carly R Varela; Jane E Minturn; Ruth Ho; Anisha M Simpson; Jennifer E Light; Audrey E Evans; Huaqing Zhao; Kenneth Thress; Jeffrey L Brown; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2012-05-24       Impact factor: 3.333

5.  Nerve growth factor: the dark side of the icon.

Authors:  Hubert Hondermarck
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

6.  Blockage of tropomyosin receptor kinase a (TrkA) enhances chemo-sensitivity in breast cancer cells and inhibits metastasis in vivo.

Authors:  Ju Zhang; Lun-Shan Wang; Shu-Lai Ye; Peng Luo; Bao-Long Wang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

7.  Intracystic papillary carcinoma of breast: interrelationship with in situ and invasive carcinoma and a proposal of pathogenesis: array comparative genomic hybridization study of 14 cases.

Authors:  Thaer Khoury; Qiang Hu; Song Liu; Jianmin Wang
Journal:  Mod Pathol       Date:  2013-08-02       Impact factor: 7.842

Review 8.  TRKing down an old oncogene in a new era of targeted therapy.

Authors:  Aria Vaishnavi; Anh T Le; Robert C Doebele
Journal:  Cancer Discov       Date:  2014-12-19       Impact factor: 39.397

Review 9.  Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain.

Authors:  Cimona V Hinton; Shalom Avraham; Hava Karsenty Avraham
Journal:  Clin Exp Metastasis       Date:  2008-09-24       Impact factor: 5.150

10.  Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.

Authors:  Radhika Iyer; Lea Wehrmann; Rebecca L Golden; Koumudi Naraparaju; Jamie L Croucher; Suzanne P MacFarland; Peng Guan; Venkatadri Kolla; Ge Wei; Nicholas Cam; Gang Li; Zachary Hornby; Garrett M Brodeur
Journal:  Cancer Lett       Date:  2016-01-18       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.